Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Hermann

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Surgery, Gynecology & Obstetrics|September 1, 1993
Partial mastectomy without radiation is adequate treatment for patients with stages 0 and I carcinoma of the breastR E Hermann, C B Esselstyn, S Grundfest-Broniatowski, et al.
Breast Cancer Research and Treatment|January 1, 1982
Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsJ P Crowe, C A Hubay, O H Pearson, et al.
Breast Cancer Research and Treatment|January 1, 1983
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year resultsO H Pearson, C A Hubay, J S Marshall, et al.
Current Surgery|January 1, 1984
The prognostic importance of estrogen receptor level for Stage I breast cancer patientsJ P Crowe, N H Gordon, C A Hubay, et al.
Surgery|July 1, 1984
Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-upC A Hubay, N H Gordon, J P Crowe, et al.
Surgery|May 1, 1980
Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary reportC A Hubay, O H Pearson, J S Marshall, et al.
European Journal of Cancer|January 1, 1980
Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancerC A Hubay, O H Pearson, J S Marshall, et al.
Cancer|December 15, 1980
Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.
Breast Cancer Research and Treatment|January 1, 1981
Adjuvant therapy of stage II breast cancer: 48-month follow-up of a prospective randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Surgery, Gynecology & Obstetrics|September 1, 1993
Partial mastectomy without radiation is adequate treatment for patients with stages 0 and I carcinoma of the breastR E Hermann, C B Esselstyn, S Grundfest-Broniatowski, et al.
Breast Cancer Research and Treatment|January 1, 1982
Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsJ P Crowe, C A Hubay, O H Pearson, et al.
Breast Cancer Research and Treatment|January 1, 1983
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year resultsO H Pearson, C A Hubay, J S Marshall, et al.
Current Surgery|January 1, 1984
The prognostic importance of estrogen receptor level for Stage I breast cancer patientsJ P Crowe, N H Gordon, C A Hubay, et al.
Surgery|July 1, 1984
Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-upC A Hubay, N H Gordon, J P Crowe, et al.
Surgery|May 1, 1980
Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary reportC A Hubay, O H Pearson, J S Marshall, et al.
European Journal of Cancer|January 1, 1980
Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancerC A Hubay, O H Pearson, J S Marshall, et al.
Cancer|December 15, 1980
Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.
Breast Cancer Research and Treatment|January 1, 1981
Adjuvant therapy of stage II breast cancer: 48-month follow-up of a prospective randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.
Pageof 12